LRP5 in premature adrenarche and in metabolic characteristics of prepubertal children

Clinical Endocrinology

Volumn 70, Issue 5, 2009, Pages 725-731

  Lappalainen, Saila ^a,b   Saarinen, Anne ^c,d   Utriainen, Pauliina ^b   Voutilainen, Raimo ^b   Jääskeläinen, Jarmo ^b   Mäkitie, Outi ^c,e  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5;

ARTICLE; CHILD; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DNA POLYMORPHISM; FEMALE; FINLAND; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; PHENOTYPE; PREMATURE ADRENARCHE; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADRENARCHE; ALLELES; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; LDL-RECEPTOR RELATED PROTEINS; LIPIDS; MALE; METABOLIC SYNDROME X; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 63149100471     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03388.x     Document Type: Article

References (48)

1. Ibanez, L., Potau, N., Chacon, P. et al. (1998) Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia, 41, 1057 1063.
2. Utriainen, P., Jääskeläinen, J., Romppanen, J. et al. (2007) Childhood metabolic syndrome and its components in premature adrenarche. Journal of Clinical Endocrinology and Metabolism, 92, 4282 4285.
3. Charkaluk, M.L., Trivin, C. Brauner, R. (2004) Premature pubarche as an indicator of how body weight influences the onset of adrenarche. European Journal of Pediatrics, 163, 89 93.
4. Guven, A., Cinaz, P. Bideci, A. (2005) Is premature adrenarche a risk factor for atherogenesis? Pediatrics International, 47, 20 25.
5. Rosenfield, R. (2007) Identifying children at risk for polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 92, 787 796.
6. Witchel, S., Smith, R., Tomboc, M. et al. (2001) Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertility and Sterility, 75, 724 730.
7. Petry, C.J., Ong, K.K., Michelmore, K.F. et al. (2005) Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Human Reproduction, 20, 1837 1843.
8. Roldan, M.B., White, C. Witchel, S.F. (2007) Association of the GAA1013→GAG polymorphism of the insulin-like growth factor-1 receptor (IGF1R) gene with premature pubarche. Fertility and Sterility, 88, 410 417.
9. Lappalainen, S., Utriainen, P., Kuulasmaa, T. et al. (2008) ACTH receptor promoter polymorphism associates with the severity of premature adrenarche and modulates the hypothalamo-pituitary-adrenal axis in children. Pediatric Research, 63, 410 414.
10. Ibanez, L., Ong, K., Mongan, N. et al. (2003) Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. Journal of Clinical Endocrinology and Metabolism, 88, 3333 3338.
11. Lappalainen, S., Utriainen, P., Kuulasmaa, T. et al. (2008) Androgen receptor gene CAG repeat polymorphism and X-chromosome inactivation in children with premature adrenarche. Journal of Clinical Endocrinology and Metabolism, 93, 1304 1309.
12. Ibanez, L., Ong, K., Potau, N. et al. (2001) Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche, and hyperinsulinism sequence. Journal of Clinical Endocrinology and Metabolism, 86, 5788 5793.
13. Ibanez, L., Marcos, M., Potau, N. et al. (2002) Increased frequency of the G972R variant of the insulin receptor substrate-1 (IRS-1) gene among girls with a history of precocious pubarche. Fertility and Sterility, 78, 1288 1293.
14. Hey, P.J., Twells, R.C., Phillips, M.S. et al. (1998) Cloning of a novel member of the low-density lipoprotein receptor family. Gene, 216, 103 111.
15. Twells, R.C., Metzker, M.L., Brown, S.D. et al. (2001) The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13. Genomics, 72, 231 242.
16. He, X., Semenov, M., Tamai, K. et al. (2004) LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development, 131, 1663 1677.
17. Gong, Y., Slee, R.B., Fukai, N. et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell, 107, 513 523.
18. Boyden, L.M., Mao, J., Belsky, J. et al. (2002) High bone density due to a mutation in LDL-receptor-related protein 5. New England Journal of Medicine, 346, 1513 1521.
19. Little, R.D., Carulli, J.P., Del Mastro, R.G. et al. (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. American Journal of Human Genetics, 70, 11 19.
20. Van Wesenbeeck, L., Cleiren, E., Gram, J. et al. (2003) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. American Journal of Human Genetics, 72, 763 771.
21. Koay, M.A., Woon, P.Y., Zhang, Y. et al. (2004) Influence of LRP5 polymorphisms on normal variation in BMD. Journal of Bone and Mineral Research, 19, 1619 1627.
22. Ferrari, S.L., Deutsch, S., Choudhury, U. et al. (2004) Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. American Journal of Human Genetics, 74, 866 875.
23. Mizuguchi, T., Furuta, I., Watanabe, Y. et al. (2004) LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density. Journal of Human Genetics, 49, 80 86.
24. Koay, M., Tobias, J., Leary, S. et al. (2007) The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcified Tissue International, 81, 1 9.
25. Kiel, D., Ferrari, S., Cupples, L. et al. (2007) Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone, 40, 587 596.
26. Saarinen, A., Välimäki, V.V., Välimäki, M.J. et al. (2007) The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men. Bone, 40, 1006 1012.
27. Kim, D.H., Inagaki, Y., Suzuki, T. et al. (1998) A new low density lipoprotein receptor related protein, LRP5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein E. Journal of Biochemistry, 124, 1072 1076.
28. Suwa, T., Chen, M., Hawks, C.L. et al. (2003) Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex. Journal of Endocrinology, 178, 149 158.
29. Heikkilä, M., Peltoketo, H., Leppäluoto, J. et al. (2002) Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology, 143, 4358 4365.
30. Mandel, H., Shemer, R., Borochowitz, Z.U. et al. (2008) SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. American Journal of Human Genetics, 82, 39 47.
31. Tissier, F., Cavard, C., Groussin, L. et al. (2005) Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Research, 65, 7622 7627.
32. Kuulasmaa, T., Jääskeläinen, J., Suppola, S. et al. (2008) WNT-4 mRNA expression in human adrenocortical tumors and cultured adrenal cells. Hormone and Metabolic Research, 40, 1 6.
33. Guo, Y., Xiong, D., Shen, H. et al. (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. Journal of Medical Genetics, 43, 798 803.
34. Suwazono, Y., Kobayashi, E., Uetani, M. et al. (2006) G-protein beta 3 subunit polymorphism C1429T and low-density lipoprotein receptor-related protein 5 polymorphism A1330V are risk factors for hypercholesterolemia in Japanese males - a prospective study over 5 years. Metabolism Clinical and Experimental, 55, 751 757.
35. Fujino, T., Asaba, H., Kang, M.J. et al. (2003) Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proceedings of the National Academy of Sciences of the United States of America, 100, 229 234.
36. Magoori, K., Kang, M.J., Ito, M.R. et al. (2003) Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. Journal of Biological Chemistry, 278, 11331 11336.
37. Rajamannan, N.M., Subramaniam, M., Caira, F. et al. (2005) Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation, 112, I229 I1234.
38. Mani, A., Radhakrishnan, J., Wang, H. et al. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science, 315, 1278 1282.
39. Sorva, R., Perheentupa, J., Lankinen, S. et al. (1990) Variation of growth in height and weight of children. II. After infancy. Acta Paediatrica Scandinavica, 79, 498 506.
40. Barrett, J.C., Fry, B., Maller, J. et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263 265.
41. Weiss, R., Dziura, J., Burgert, T.S. et al. (2004) Obesity and the metabolic syndrome in children and adolescents. New England Journal of Medicine, 350, 2362 2374.
42. Chen, M. Hornsby, P.J. (2006) Adenovirus-delivered DKK3/WNT4 and steroidogenesis in primary cultures of adrenocortical cells. Hormone and Metabolic Research, 38, 549 555.
43. Meas, T., Chevenne, D., Thibaud, E. et al. (2002) Endocrine consequences of premature pubarche in post-pubertal Caucasian girls. Clinical Endocrinology, 57, 101 106.
44. Andiran, N. Yordam, N. (2008) Lipoprotein(a) levels in girls with premature adrenarche. Journal of Paediatrics and Child Health, 44, 138 142.
45. Ibanez, L., Dimartino-Nardi, J., Potau, N. et al. (2000) Premature adrenarche - normal variant or forerunner of adult disease? Endocrine Reviews, 21, 671 696.
46. Wang, Z., Shu, W., Lu, M.M. et al. (2005) Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. Molecular and Cellular Biology, 25, 5022 5030.
47. Suwazono, Y., Kobayashi, E., Uetani, M. et al. (2006) Low-density lipoprotein receptor-related protein 5 variant A1330V is a determinant of blood pressure in Japanese males. Life Sciences, 78, 2475 2479.
48. Baron, R. Rawadi, G. (2007) Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology, 148, 2635 2643.